CisplatinPlatinum CompoundsAntineoplastic AgentsOrganoplatinum CompoundsAntineoplastic Combined Chemotherapy ProtocolsCarboplatinOvarian NeoplasmsDNA AdductsDrug Resistance, NeoplasmPlatinumPaclitaxelLung NeoplasmsDrug Administration ScheduleDrug Screening Assays, AntitumorDeoxycytidineEtoposideCombined Modality TherapyTreatment OutcomeVinblastineCell Line, TumorFluorouracilTaxoidsCarcinoma, Non-Small-Cell LungHead and Neck NeoplasmsDose-Response Relationship, DrugTumor Cells, CulturedIfosfamideCyclohexylaminesSurvival AnalysisNeoplasms, Glandular and EpithelialDrug SynergismCarcinoma, Squamous CellInfusions, IntravenousVomitingDoxorubicinDisease-Free SurvivalLeukopeniaCell SurvivalCoordination ComplexesDrug ResistanceApoptosisDNA DamageSurvival RateChloroacetatesDNA RepairCross-Linking ReagentsLeukemia L1210NeoplasmsEmbolization, TherapeuticAntineoplastic Agents, PhytogenicNeoplasm StagingTesticular NeoplasmsPalladiumAdenocarcinomaNauseaCarcinoma, Small CellDrug EvaluationCamptothecinDNANeutropeniaMitomycinSpectrophotometry, AtomicGuanineNeoplasm Recurrence, LocalInhibitory Concentration 50Neoplasms, Germ Cell and EmbryonalStomach NeoplasmsBleomycinCarcinomaMesotheliomaThrombocytopeniaVindesineOxonic AcidRhodiumGlutathionePeritoneal NeoplasmsMaximum Tolerated DoseTime FactorsIntracranial AneurysmAmifostineKidneyChemotherapy, AdjuvantSalvage TherapyMice, NudeEndonucleasesAntimetabolites, AntineoplasticTegafurDNA, NeoplasmPleural NeoplasmsEsophageal NeoplasmsEpirubicinRadiation-Sensitizing AgentsGene Expression Regulation, NeoplasticTumor Suppressor Protein p53GerminomaCystadenocarcinoma, SerousCyclophosphamideXenograft Model Antitumor AssaysBridged CompoundsUterine Cervical Neoplasms